Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Summary

The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate the effect of XmAb541 on tumor outcomes.

Timeline

Start

2024-04-04

Primary completion

2027-12

Completion

2028-12

Drugs

Indications